Related Experiment Videos
Antibacterial agents--phagocytes: new concepts for old in immunomodulation
1INSERM U479, Laboratoire d'Hematologie et d'Immunologie, CHU Xavier Bichat, Paris, France.
International Journal of Antimicrobial Agents
|June 13, 1998
Summary
Antibacterial drugs can influence host immune cells, like phagocytes, beyond fighting infections. This review explores these non-antimicrobial effects for potential new therapies in infectious and non-infectious diseases.
Area of Science:
- Immunology
- Pharmacology
- Microbiology
Background:
- Antibacterial agents primarily target microorganisms but also affect host functions.
- Non-antimicrobial effects of antibiotics are crucial for preventing toxicity and represent a novel therapeutic avenue.
- Interactions between antibacterial drugs and the immune system, particularly phagocytes, are vital for both infectious disease treatment and immune modulation.
Purpose of the Study:
- To review the interactions between antibacterial agents and phagocytes.
- To explore the future prospects of these interactions in both infectious and non-infectious diseases.
- To highlight the potential of antibacterial agents as immune response modifiers.
Main Methods:
- Literature review of existing research on antibacterial agents and phagocyte interactions.
- Analysis of non-antimicrobial effects of antibiotics on host immune functions.
- Exploration of therapeutic applications beyond infectious diseases.
Main Results:
- Antibacterial agents possess significant non-antimicrobial effects on host immune cells.
- Phagocytes are key targets for immune modulation by antibacterial agents.
- These interactions offer potential for developing new treatments for non-infectious conditions.
Conclusions:
- Antibacterial agents have a dual role, combating pathogens and modulating host immunity.
- Understanding these interactions opens new avenues for drug development in non-infectious diseases.
- Future research should focus on harnessing these effects for novel therapeutic strategies.